Ninian Lang

Cardiologist @UofGlasgow @NHSGGC. Cardio-oncology, Heart Failure. Assoc Editor @JACC CardioOncology. Tweets own views, not medical advice.

[Ninian Lang @ninianlang]

Register here: https://t.co/hJ2i3nEnuy

[JACC Journals @JACCJournals]

Cancer therapies can carry CV risks, but current safety tools fall short. The Cardiac Safety Research Consortium led a multi-stakeholder think tank to improve CV safety reporting in oncology trials. Read the findings + next steps in #JACCCardioOnc: https://t.co/2asnZ6Vlxu

[Gerard Walls @gwalls89]

Have you got a history of heart disease and/or cancer? Or are you the relative of someone who has?

Our CardioOncology research group is gathering the public's opinion on what our priorities should be!

✅ only takes 15mins
✅ completely confidential

https://t.co/vPD5yjSuWT

[Novi Yanti Sari @slumberbell]

Learn about the practical guide to cardiotoxicity risk stratification, straight from the #ESC guidelines. #ESCardioOnco

Join the webinar🔗: https://t.co/uHAr2Kf4x4

[Heart Failure Hub Scotland @HFHubScotland]

Professor @markcpetrie20 takes us through detecting the aetiology of heart failure

🫀 need to do more digging rather than label of HFpEF or HFrEF
🫀 be comprehensive - genetics, drugs
🫀 Inflammatory cardiomyopathies are more common than you think!

[Gerard Walls @gwalls89]

If you treat lung cancer & have queries about radiation heart disease then check out this new @WashUMedRadOnc paper!

100 years on from its 1st description we summarise what is known (and not known) & highlight priorities for the field to maximise patient benefit

[Gerard Walls @gwalls89]

Thoracic RadOncs should check out our paper in this month's Clinical Oncology

https://t.co/d1U40sBpLU

We worked with the International Cardio-Oncology Society to develop a survey for stock-taking practice in lung cancer radiotherapy & to identify key gaps & solutions

[JACC Journals @JACCJournals]

#JACCCardioOnc EiC Dr. Bonnie Ky @PennThalheimer on next steps regarding SARAH trial, #AHA24:
🔹Advance precision medicine
🔹Identify high-risk populations who benefit from cardioprotection
🔹Develop rigorous consensus definitions of clinically relevant endpoints
🔹Define impact on longer term clinical outcomes

📎: https://t.co/atp8XAdsrq #CardioOnc

[Ronald Witteles @Ron_Witteles]

👀 #ImpactFactor for @JACCJournals #JACC:CardioOncology has been recalculated for 2023 — up to 13.6! 😮 Ranks #8/222 Cardiology journals (and 18/322 Oncology journals) in the 🌎. Meteoric rise & a testament to the amazing #BonnieKy and an incredible #CardioOnc community. @PennThalheimer @ArmenianSaro @ninianlang @dineshpmcc1 @DarrylLeong @carmenbergom @gmelendezMD @p_van_der_meer @yurikim_mdphd @ericchowmd @SWaliany @Richardkcheng2 @anguyen4194 @HanZhuMD

[British Cardiovascular Society @BritishCardioSo]

Only 5 weeks to go to the booking deadline for the @BritishCardioSo @BCOSCardioOnc @uclh Cancer Academy Cardio-Oncology Course - a fantastic range of speakers, sessions for oncologists and haematologists.

🗓️Monday 11 November 2024
📍 @RCPhysicians

https://t.co/60w2ixW6DQ

[BCOS @BCOSCardioOnc]

This will inform future discussions and funding applications for collaborative UK cardio-oncology research. For further information, please contact [email protected].

[BCOS @BCOSCardioOnc]

Please take 10 minutes to complete this short survey (https://t.co/NHvVQgzQBf), which seeks to gain an overview of opinions from UK-based healthcare professionals in relation to cardio-oncology research priorities.

[BCOS @BCOSCardioOnc]

Do you have a specialist interest in cardio-oncology & would like to help inform future research priorities? The NIHR-BHF Cardiovascular Partnership theme in Cardio-Oncology is keen to hear from you to help facilitate future study design & maximise collaboration across the UK.

[Professor Arjun Ghosh (London Cardio-Oncology) @arjunkg]

This joint @BritishCardioSo @BCOSCardioOnc and @UCLH Cancer Academy course will give the attendee an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology.
https://t.co/LOJsWWVk63

[BSEcho @BSEcho]

We are highlighting the sessions you can expect at BSEcho 2024 - we're excited to see you in Edinburgh!

See the programme for our cardio-oncology session in association with @BCOSCardioOnc

👇 View the full programme and book on our website: https://t.co/Vw1lO2C7VN

[American College of Cardiology @ACCinTouch]

The PROACT trial found adding enalapril to standard care during chemotherapy did not prevent cardiotoxicity in patients receiving high-dose anthracycline-based chemotherapy.

Read more on the trial: https://t.co/WPIPe6UM8N #ACCLATAM

[Ana Barac, MD, PhD, FACC, FAHA @AnaBaracCardio]

Much of great science starts with a poster. #ESCCongress2024 had a phenomenal #Cardioonc line-up, hard to cover it all! Great homework x Editors 😉@JACCJournals @ESC_Journals @AHAScience Kudos to ALL presenters&mentors & @escardio! @TeresaLpezFdez1

[JACC Journals @JACCJournals]

Don’t miss an opportunity to join #JACCCardioOnc Editor-in-Chief Bonnie Ky, MD, MSCE, FACC, to discuss manuscript ideas, works in progress and new ideas during #ESCCongress 2024! Walk in and take advantage of 1:1 discussion time with bi-directional feedback on your work. Learn More: https://t.co/NUYS5KVHlF

[Ronald Witteles @Ron_Witteles]

Wow!!! 🤯 New #ImpactFactor release and another record for @JACCJournals JACC: CardioOncology! < 5 years old and already the #9 Cardiology journal in the 🌎 and #2 #JACC subjournal. Amazing leadership from #BonnieKy! 🙂 @ArmenianSaro @ninianlang @dineshpmcc1 @PennThalheimer